Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 222 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Emotional Sensitivity test Clear all

Conditions: Type 2 Diabetes
Interventions: Not listed
Lead sponsor: Foundation for the National Institutes of Health; Other
Eligibility: 30 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Down Syndrome, Edwards Syndrome, Patau Syndrome, Klinefelter Syndrome, Turner Syndrome, DiGeorge Syndrome, Chromosome Deletion, Aneuploidy
Interventions: Blood sampling for Laboratory Developed Test (LDT) analysis; Other
Lead sponsor: Progenity, Inc.; Industry
Eligibility: 18 Years to 54 Years · Female only
Enrollment: 760 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 8
States / cities: Scottsdale, Arizona • Eunice, Louisiana • Brooklyn, New York + 5 more

Conditions: Metabolic Syndrome, Obesity
Interventions: Single Bout of Exercise, Control Condition; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 40 Years to 70 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Actinic Keratosis
Interventions: Ingenol Mebutate (Picato®), Generic Ingenol Mebutate, Vehicle Foam; Drug
Lead sponsor: Actavis Inc.; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 441 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 22
States / cities: Fremont, California • San Diego, California • Aventura, Florida + 19 more

Conditions: Instructional Methods
Interventions: Conceptual teaching; Other
Lead sponsor: Sentara Norfolk General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Ischemic Stroke
Interventions: Nautilus NeuroWaveTM System; Device
Lead sponsor: Jan Medical, Inc.; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 3
States / cities: Baltimore, Maryland • Columbia, Maryland

Conditions: Irritable Bowel Syndrome
Interventions: Personalized Dietary Advice; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Cardiomyopathy
Interventions: Sympathetic Nerve Activity, Mental Stress Test (Color Word Test), The Modified Oxford Technique for Baroreflex Sensitivity, Cold Pressor Test, Echocardiographic evaluation; Device · Behavioral · Drug + 1 more
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 21 Years to 90 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Cough, Parkinson's Disease
Interventions: Capsaicin, Voluntary cough test; Drug · Other
Lead sponsor: University of Florida; Other
Eligibility: 55 Years to 85 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Cardiovascular Diseases, Insulin Sensitivity/Resistance, Metabolic Disease, Metabolism, Energy Expenditure, Obesity
Interventions: Vericiguat 10 MG, Placebo, Insulin Sensitivity Test, Resting Energy and Exercise Energy Expenditure Assessment, White Adipose Tissue Biopsy, MRI-PET Scan for Brown Adipose Tissue Volume Assessment; Drug · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Vision, Low, Blindness
Interventions: Single bump acuity, Optimal spacing between bumps, Improving signal from a single bump with designer materials; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 16 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Conjunctivitis
Interventions: RPS Adeno Detector IV; Device
Lead sponsor: Rapid Pathogen Screening; Industry
Eligibility: 1 Year and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 8
States / cities: Bradenton, Florida • Miami, Florida • Springfield, Missouri + 5 more

Conditions: Gastroesophageal Reflux
Interventions: Nickel-free diet; Other
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Morgantown, West Virginia

Conditions: Acute Myocardial Infarction, Acute Coronary Syndrome
Interventions: Cardiac Troponin Testing; Diagnostic Test
Lead sponsor: Hennepin Healthcare Research Institute; Other
Eligibility: 21 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Colorectal Cancer Screening
Interventions: DA - Quantitative, DA - Verbal; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 50 Years to 75 Years
Enrollment: 728 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Photophobia, Traumatic Brain Injury, Migraine
Interventions: Pupillography, Ocular Coherence Tomography (OCT), Wrist-watch sensor device, Videography, Electrophysiology; Device
Lead sponsor: Randy Kardon; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Videofluoroscopic Swallowing Study (VFSS), Voluntary Peak Cough Flow Testing, Iowa Oral Performance Instrument, Capsaicin Challenge, Pulmonary Function Testing, Eating Assessment Tool 10, The Center for Neurologic Study Bulbar Function Scale; Procedure · Device · Drug + 1 more
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 90 Years
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 2
States / cities: Gainesville, Florida • Tampa, Florida

Conditions: Plaque, Dental
Interventions: Colgate Cavity Protection, TOM's Superior Sensitivity Relief Toothpaste; Drug
Lead sponsor: Colgate Palmolive; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Fibromyalgia
Interventions: Paced Auditory Serial Addition task (PASAT); Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Mild Cognitive Impairment, Metabolic Syndrome
Interventions: Dietary intervention; Behavioral
Lead sponsor: Bristlecone Health, Inc.; Industry
Eligibility: 35 Years to 80 Years
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Maple Grove, Minnesota

Conditions: SARS-CoV2 Infection, COVID-19
Interventions: iCura COVID-19 Antigen Rapid Home Test, RT-PCR Test; Device
Lead sponsor: MP Biomedicals, LLC; Industry
Eligibility: 2 Years and older
Enrollment: 332 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 4
States / cities: DeLand, Florida • Gainesville, Florida • St. Petersburg, Florida + 1 more

Conditions: Alzheimer Disease
Interventions: Memantine; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 50 Years to 83 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: San Diego, California

Conditions: Essential Tremor
Interventions: Limb Cooling Assessment of ET; Procedure
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 95 Years
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Heart Failure
Interventions: Anakinra; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 21 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Richmond, Virginia

Search by objective public record fields.

Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes

Expanded Noninvasive Genomic Medical Assessment: The Enigma Study

Impact of Acute Exercise on Vascular Insulin Sensitivity in Metabolic Syndrome

A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis

A Study to Evaluate Strategies for Teaching Effective Use of Diagnostic Tests

Study to Test Sensitivity and Specificity of Passive Wave Pressure Device in Determining Ischemic Stroke

Irritable Bowel Syndrome and Food Sensitivity

Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy

Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's Disease

VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine Mono-Phosphate Signaling Pathway

Testing Tactile Aids With Blind Subjects

A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis

Effect of a Nickel Free Diet and Nickel Sensitization on GERD Patients.

Safe Emergency Department DIscharGE Rate (SEIGE)

Information With or Without Numbers For Optimizing Reasoning About Medical Decisions

Objectively Diagnose and Monitor Treatment of Light Sensitivity

Delineating Swallowing Impairment and Decline in ALS

Arginine Plaque Metabolism Pilot Clinical Study

Generalized Hypersensitivity in Patients With Fibromyalgia Syndrome

Dietary Ketosis: Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation

COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation

Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease

Limb Cooling in Essential Tremor

The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)